L-Stepholidine rescues memory deficit and synaptic plasticity in models of Alzheimer's disease via activating dopamine D1 receptor/PKA signaling pathway

Cell Death and Disease

Volumn 6, Issue , 2015, Pages

  Hao, J R ^a   Sun, N ^a   Lei, L ^a   Li, X Y ^a   Yao, B ^a   Sun, K ^a   Hu, R ^a   Zhang, X ^a   Shi, X D ^a   Gao, C ^a  

^a XUZHOU MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; AMPA RECEPTOR; AMYLOID PRECURSOR PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; GLUTAMATE RECEPTOR; GLUTAMATE RECEPTOR A1; PRESENILIN 1; STEPHOLIDINE; UNCLASSIFIED DRUG; BERBERINE; DOPAMINE RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT;

ALZHEIMER DISEASE; AMNESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITION; CONTROLLED STUDY; DENSITY; DRUG MECHANISM; HIPPOCAMPAL NEURONAL CULTURE; HIPPOCAMPAL SLICE; LOCOMOTION; LONG TERM POTENTIATION; MEMORY; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANALOGS AND DERIVATIVES; ANIMAL; GENETICS; MALE; MEMORY DISORDERS; METABOLISM; PATHOLOGY; RAT; SPRAGUE DAWLEY RAT; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; ANIMALS; ANTIPSYCHOTIC AGENTS; BERBERINE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOPAMINE AGONISTS; MALE; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D1; SIGNAL TRANSDUCTION;

EID: 84946575191     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2015.315     Document Type: Article

References (46)

1. Krafft GA, Klein WL. ADDLs and the signaling web that leads to Alzheimer's disease. Neuropharmacology 2010; 59: 230-242.
2. Ferreira ST, Klein WL. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease. Neurobiol Learn Mem 2011; 96: 529-543.
3. Malinow R, Malenka RC. AMPA receptor trafficking and synaptic plasticity. Annu Rev Neurosci 2002; 25: 103-126.
4. Ren SQ, Yan JZ, Zhang XY, Bu YF, Pan WW, Yao W et al. PKC? is critical in AMPA receptor phosphorylation and synaptic incorporation during LTP. EMBO J 2013; 32: 1365-1368.
5. Whitehead G, Jo J, Hogg EL, Piers T, Kim DH, Seaton G et al. Acute stress causes rapid synaptic insertion of Ca2+-permeable AMPA receptors to facilitate long-term potentiation in the hippocampus. Brain 2013; 136: 3753-3765.
6. Wenthold RJ, Petralia RS, Niedzielski AS. Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons. J Neurosci 1996; 16: 1982-1989.
7. Lu W, Shi Y, Jackson AC, Bjorgan K, During MJ, Sprengel R et al. Subunit composition of synaptic AMPA receptors revealed by a single-cell genetic approach. Neuron 2009; 62: 254-268.
8. Kessels HW, Malinow R. Synaptic AMPA receptor plasticity and behavior. Neuron 2009; 61: 340-350.
9. Mao LM, Diaz JA, Fibuch EE, Wang JQ. Regulation of phosphorylation of synaptic and extrasynaptic GluA1 AMPA receptors in the rat forebrain by amphetamine. Eur J Pharmacol 2013; 715: 164-171.
10. Miñano-Molina AJ, España J, Martín E, Barneda-Zahonero B, Fadó R, Solé M et al. Soluble oligomers of amyloid-β peptide disrupt membrane trafficking of a-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptor contributing to early synapse dysfunction. J Biol Chem 2011; 286: 27311-27321.
11. Oh MC, Derkach VA, Guire ES, Soderling TR. Extrasynaptic membrane trafficking regulated by GluR1 serine 845 phosphorylation primes AMPA receptors for long-term potentiation. J Biol Chem 2006; 281: 752-758.
12. Gao C, Sun X, Wolf ME. Activation of D1 dopamine receptors increases surface expression of AMPA receptors and facilitates their synaptic incorporation in cultured hippocampal neurons. J Neurochem 2006; 98: 1664-1677.
13. Jürgensen S, Antonio LL, Mussi GEA, Brito-Moreira J, Bomfim TR, De Felice FG et al. Activation of D1/D5 dopamine receptors protects neurons from synapse dysfunction induced by amyloid-β oligomers. J Biol Chem 2011; 286: 3270-3276.
14. Mo J, Zhang H, Yu LP, Sun PH, Jin GZ, Zhen X. L-stepholidine reduced L-DOPA-induced dyskinesia in 6-OHDA-lesioned rat model of Parkinson's disease. Neurobiol Aging 2010; 31: 926-936.
15. Natesan S, Reckless GE, KBL Barlow, Odontiadis J, Nobrega JN, Baker GB et al. The antipsychotic potential of l-stepholidine - a naturally occurring dopamine receptor D1 agonist and D2 antagonist. Psychopharmacology 2008; 199: 275-289.
16. Webster SJ, Bachstetter AD, Nelson PT, Schmitt FA, Van Eldik LJ. Using mice to model Alzheimer's dementia: an overview of the clinical disease and the preclinical behavioral changes in 10 mouse models. Front Genet 2014; 5: 88.
17. Henley JM, Barker EA, Glebov OO. Routes, destinations and delays: recent advances in AMPA receptor trafficking. Trends Neurosci 2011; 34: 258-268.
18. Opazo P, Choquet D. A three-step model for the synaptic recruitment of AMPA receptors. Mol Cell Neurosci 2011; 46: 1-8.
19. Oh MC, Derkach VA. Dominant role of the GluR2 subunit in regulation of AMPA receptors by CaMKII. Nat Neurosci 2005; 8: 853-854.
20. Choquet D. Fast AMPAR trafficking for a high-frequency synaptic transmission. Eur J Neurosci 2010; 32: 250-260.
21. Anggono V, Huganir RL. Regulation of AMPA receptor trafficking and synaptic plasticity. Curr Opin Neurobiol 2012; 22: 461-469.
22. Selkoe DJ. Soluble oligomers of the amyloid β-protein impair synaptic plasticity and behavior. Behav Brain Res 2008; 192: 106-113.
23. Zhao WQ, Santini F, Breese R, Ross D, Zhang XD, Stone DJ et al. Inhibition of calcineurinmediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J Biol Chem 2010; 285: 7619-7632.
24. Lee S, Song B, Kim J, Park K, Hong I, An B et al. GluA1 phosphorylation at serine 831 in the lateral amygdala is required for fear renewal. Nat Neurosci 2013; 16: 1436-1444.
25. Hu H, Real E, Takamiya K, Kang MG, Ledoux J, Huganir RL et al. Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell 2007; 131: 160-173.
26. Beninger RJ, Miller R. Dopamine D1-like receptors and reward-related incentive learning. Neurosci Biobehav Rev 1998; 22: 335-345.
27. Gao C, Wolf ME. Dopamine alters AMPA receptor synaptic expression and subunit composition in dopamine neurons of the ventral tegmental area cultured with prefrontal cortex neurons. J Neurosci 2007; 27: 14275-14285.
28. Li S, Jin M, Zhang D, Yang T, Koeglsperger T, Fu H et al. Environmental Novelty Activates β2-Adrenergic Signaling to Prevent the Impairment of Hippocampal LTP by Aβ Oligomers. Neuron 2013; 77: 929-941.
29. Jin GZ, Zhu ZT, Fu Y. Stepholidine: a potential novel antipsychotic drug with dual D1 receptor agonist and D2 receptor antagonist actions. Trends Pharmacol Sci 2002; 23: 4-7.
30. Gao M, Liu CL, Yang S, Zhen XC, Jin GZ. l-Stepholidine increases the frequency of sEPSC via the activation of D1 dopamine signaling pathway in rat prelimbic cortical neurons. Acta Pharmacol Sin 2007; 28: 627-633.
31. Fortin DA, Srivastava T, Soderling TR. Structural modulation of dendritic spines during synaptic plasticity. Neuroscientist 2012; 18: 326-341.
32. Sun Y, Dai J, Hu Z, Du F, Niu W, Wang F et al. Oral bioavailability and brain penetration of (-)-stepholidine, a tetrahydroprotoberberine agonist at dopamine D1 and antagonist at D2 receptors, in rats. Br J Pharmacol 2009; 158: 1302-1312.
33. Jankowsky JL, Slunt HH, Ratovitski T, Jenkins NA, Copeland NG, Borchelt DR. Coexpression of multiple transgenes in mouse CNS: a comparison of strategies. Biomol Eng 2001; 17: 157-165.
34. Cao DF, Lu H, Lewis TL, Li L. Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem 2007; 282: 36275-36282.
35. Ding Y, Qiao A, Wang Z, Goodwin JS, Lee ES, Block ML et al. Retinoic acid attenuates β-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model. J Neurosci 2008; 28: 11622-11634.
36. Cramer PE, Cirrito JR,Wesson DW, Lee CY, Karlo JC, Zinn AE et al. ApoE-directed therapeutics rapidly clear β-amyloid and reverse deficits in ADmouse models. Science 2012; 335: 1503-1506.
37. Cissé M, Halabisky B, Harris J, Devidze N, Dubal DB, Sun B et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 2011; 469: 47-52.
38. Murakami K, Shimizu T. Cytoplasmic superoxide radical: a possible contributing factor to intracellular Aβ oligomerization in Alzheimer disease. Commun Integr Biol 2012; 5: 255-258.
39. Filali M, Lalonde R, Theriault P, Julien C, Calon F, Planel E. Cognitive and non-cognitive behaviors in the triple transgenic mouse model of Alzheimer's disease expressing mutated APP, PS1, and Mapt(3xTg-AD). Behav Brain Res 2012; 234: 334-342.
40. Filali M, Lalonde R, Rivest S. Cognitive and non-cognitive behaviors in an APPswe/PS1 bigenic model of Alzheimer's disease. Genes Brain Behav 2009; 8: 143-148.
41. Rönicke R, Mikhaylova M, Rönicke S, Meinhardt J, Schröder UH, Fändrich M et al. Early neuronal dysfunction by amyloid β oligomers depends on activation of NR2B-containing NMDA receptors. Neurobiol Aging 2011; 32: 2219-2228.
42. Gao C, Frausto SF, Guedea AL, Tronson NC, Jovasevic V, Leaderbrand K et al. IQGAP1 regulates NR2A signaling, spine density, and cognitive processes. J Neurosci 2011; 31: 8533-8542.
43. Sun N, Hao JR, Li XY, Yin XH, Zong YY, Zhang GY et al. GluR6-FasL-Trx2 mediates denitrosylation and activation of procaspase-3 in cerebral ischemia/reperfusion in rats. Cell Death Dis 2013; 4: e771.
44. Volk LJ, Bachman JL, Johnson R, Yu Y, Huganir RL. PKM is not required for hippocampal synaptic plasticity, learning and memory. Nature 2013; 493: 420-423.
45. Townsend M, Shankar GM, Mehta T, Walsh DM, Selkoe DJ. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J Physiol 2006; 572: 477-492.
46. Ren WJ, Liu Y, Zhou LJ, Li W, Zhong Y, Pang RP et al. Peripheral nerve injury leads to working memory deficits and dysfunction of the hippocampus by upregulation of TNF-a in rodents. Neuropsychopharmacology 2011; 36: 979-992.